Constant Beroulle - Newfund Capital

Sign in Subscribe

Constant Beroulle

Techbio and its applications in BrainTech: an investor perspective

Techbio and its applications in BrainTech: an investor perspective

We have decided to dedicate a series of articles on the BrainTech market to show our investor perspective. After discussing the Brain Technology Revolution, Brain and Nutrition, BCI, Psychedelics and Sleep tech, Skills Enhancement this new article deals with the current state of Techbio and its applications in BrainTech. Introduction

Exploring Opportunities in the Nordic Countries

Exploring Opportunities in the Nordic Countries

With our new BrainTech-focused investment strategy, Heka, we are expanding our geographic scope beyond the US and France. We're actively seeking to identify the next Brain Capital champion in both Europe and the US. This endeavor requires us to delve into and understand new, fascinating ecosystems. We'

Skills enhancement startups: an investor point of view

Skills enhancement startups: an investor point of view

We have decided to dedicate a series of articles on the BrainTech market to show our investor perspective. After discussing the Brain Technology Revolution, Brain and Nutrition, BCI, Psychedelics and Sleep tech, this new article deals with Skills Enhancement. Introduction Skills are defined as cleverness at doing something, resulting either

The SleepTech Industry: an Investor Perspective

The SleepTech Industry: an Investor Perspective

Introduction We have decided to dedicate a series of articles on the BrainTech market to show our investor perspective. After discussing the Brain Technology Revolution, Brain and Nutrition, BCI, and Psychedelics, this fifth article deals with the SleepTech industry. The SleepTech industry is defined as ‘the sector of technology and

Psychedelics: an investor perspective

Psychedelics: an investor perspective

We decided to dedicate a whole series of articles on the BrainTech market, to show the richness that this sector can reveal and to address the most controversial topics. After talking about BCI, this second article deals with the psychedelic market. The past decade has ushered in a renaissance in

Brain Computer Interface : an investor perspective

Brain Computer Interface : an investor perspective

BrainTech is the new emerging sector of innovation, and as such, provokes both excitement and fear. Especially since it involves the most important organ of our body, and yet, the one we still don’t fully understand. It's been a while, however, that BrainTech is a no-brainer for